Sándor Kolok

620 total citations
27 papers, 424 citations indexed

About

Sándor Kolok is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Sándor Kolok has authored 27 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Sándor Kolok's work include Neuroscience and Neuropharmacology Research (18 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (9 papers). Sándor Kolok is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (9 papers). Sándor Kolok collaborates with scholars based in Hungary, Netherlands and Japan. Sándor Kolok's co-authors include András Mihály Boros, József Nagy, Zsolt Szombathelyi, György Domány, Anikó Gere, Sándor Farkas, László Fodor, István Greiner, György M. Keserű and C Horváth and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Medicinal Chemistry.

In The Last Decade

Sándor Kolok

26 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sándor Kolok Hungary 14 210 195 124 46 30 27 424
Nicholas D. Smith United States 8 234 1.1× 256 1.3× 194 1.6× 61 1.3× 27 0.9× 9 529
Ria Wouters Belgium 7 201 1.0× 208 1.1× 86 0.7× 40 0.9× 23 0.8× 8 396
Frédéric Fabis France 13 176 0.8× 95 0.5× 217 1.8× 63 1.4× 56 1.9× 26 460
Geoffrey Hornby United States 11 187 0.9× 158 0.8× 150 1.2× 51 1.1× 65 2.2× 13 369
Kerry L. Chapman United Kingdom 12 279 1.3× 193 1.0× 112 0.9× 29 0.6× 20 0.7× 21 469
Sham S. Nikam United States 18 339 1.6× 207 1.1× 310 2.5× 75 1.6× 42 1.4× 28 696
Justin R. Nickell United States 12 230 1.1× 272 1.4× 83 0.7× 28 0.6× 46 1.5× 26 443
Sylvain Célanire France 13 341 1.6× 216 1.1× 127 1.0× 48 1.0× 60 2.0× 24 572
Thomas J. Bleisch United States 10 222 1.1× 195 1.0× 167 1.3× 13 0.3× 25 0.8× 14 432
François Bischoff Belgium 13 365 1.7× 345 1.8× 170 1.4× 98 2.1× 58 1.9× 22 681

Countries citing papers authored by Sándor Kolok

Since Specialization
Citations

This map shows the geographic impact of Sándor Kolok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sándor Kolok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sándor Kolok more than expected).

Fields of papers citing papers by Sándor Kolok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sándor Kolok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sándor Kolok. The network helps show where Sándor Kolok may publish in the future.

Co-authorship network of co-authors of Sándor Kolok

This figure shows the co-authorship network connecting the top 25 collaborators of Sándor Kolok. A scholar is included among the top collaborators of Sándor Kolok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sándor Kolok. Sándor Kolok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szabó, György, Sándor Kolok, Mónika Vastag, et al.. (2019). Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs). European Journal of Medicinal Chemistry. 186. 111881–111881. 5 indexed citations
2.
Galambos, János, György Domány, György M. Keserű, et al.. (2016). 4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate. Bioorganic & Medicinal Chemistry Letters. 26(4). 1249–1252. 18 indexed citations
3.
Kolok, Sándor, et al.. (2016). New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds. Bioorganic & Medicinal Chemistry Letters. 26(16). 3896–3904. 4 indexed citations
4.
Kolok, Sándor, et al.. (2016). New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones. Bioorganic & Medicinal Chemistry Letters. 26(16). 3905–3912. 5 indexed citations
5.
Domány, György, Sándor Kolok, Mónika Vastag, et al.. (2015). Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Lead optimization. Bioorganic & Medicinal Chemistry Letters. 25(8). 1724–1729. 14 indexed citations
6.
Nagy, József, et al.. (2014). Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α2C receptor. Brain Research Bulletin. 107. 89–101. 8 indexed citations
7.
Domány, György, Béla Kiss, Sándor Kolok, et al.. (2014). Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Hit-to-lead optimization. Bioorganic & Medicinal Chemistry Letters. 24(16). 3845–3849. 7 indexed citations
8.
Éles, János, Éva Bozó, Ákos Tarcsay, et al.. (2012). Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(9). 3095–3099. 20 indexed citations
9.
Wéber, Csaba, László Molnár, Attila Horváth, et al.. (2010). Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs. Bioorganic & Medicinal Chemistry Letters. 20(12). 3737–3741. 18 indexed citations
10.
Galambos, János, László Molnár, Attila Horváth, et al.. (2010). Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(15). 4371–4375. 20 indexed citations
11.
Kolok, Sándor, Anikó Gere, József Nagy, et al.. (2006). Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(17). 4638–4640. 14 indexed citations
12.
13.
Kolok, Sándor, Anikó Gere, C Horváth, et al.. (2006). Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(2). 406–409. 33 indexed citations
14.
Kolok, Sándor, István Greiner, Gábor Tárkányi, et al.. (2005). Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(24). 5439–5441. 15 indexed citations
15.
Nagy, Judit, et al.. (2005). Role of Altered Structure and Function of NMDA Receptors in Development of Alcohol Dependence. Current Neuropharmacology. 3(4). 281–297. 22 indexed citations
16.
Kocsis, Pál, Sándor Farkas, László Fodor, et al.. (2005). Tolperisone-Type Drugs Inhibit Spinal Reflexes via Blockade of Voltage-Gated Sodium and Calcium Channels. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1237–1246. 50 indexed citations
17.
Boros, András Mihály, et al.. (2005). Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors. Neurochemistry International. 46(5). 369–379. 10 indexed citations
18.
Nagy, József, et al.. (2003). Inducible expression and pharmacology of recombinant NMDA receptors, composed of rat NR1a/NR2B subunits. Neurochemistry International. 43(1). 19–29. 19 indexed citations
19.
Kolok, Sándor, Anikó Gere, Éva Ágai-Csongor, et al.. (2003). Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(21). 3859–3861. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas D. Smith Breakdown of academic impact, for papers by Ria Wouters Breakdown of academic impact, for papers by Frédéric Fabis Breakdown of academic impact, for papers by Geoffrey Hornby Breakdown of academic impact, for papers by Kerry L. Chapman Breakdown of academic impact, for papers by Sham S. Nikam Breakdown of academic impact, for papers by Justin R. Nickell Breakdown of academic impact, for papers by Sylvain Célanire Breakdown of academic impact, for papers by Thomas J. Bleisch Breakdown of academic impact, for papers by François Bischoff
Rankless by CCL
2026